Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
CHAPEL HILL, N.C., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
- Oncolytic virus enhances immune checkpoint inhibitor response in prostate cancers - CALGARY, Alberta ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email